//
Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery
H2FPEF Score for Predicting Future Heart Failure in Stable Outpatients With Cardiovascular Risk Factors
AIM2-driven inflammasome activation in heart failure
Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study
Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure
The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE
Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes
Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"